Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
FDA Orders Cartridge-Based E-Cigarette Flavors Removed From Sale Within 30 Days January 3, 2020 Irvin Jackson Add Your CommentsE-cigarette manufacturers have 30 days to remove all flavored, cartridge-based products from the market, except for tobacco or menthol flavors, or the manufactures will face enforcement actions from federal regulators.The FDA issued a press release on Thursday, announcing a flavored e-cigarette cartridge enforcement policy, which has been anticipated for months.The action is aimed at preventing companies from continuing to sell products that entice children and teens to vape, fueling the growing nicotine addiction problems among prior non-smokers in the United States. The agency indicates that its new policy prioritizing enforcement against the multitude of flavored products, will prevent the sale of products the FDA says were never approved.LEARN MORE ABOUTVAPE PEN AND E-CIG LAWSUITSSerious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONLearn More AboutVAPE PEN AND E-CIG LAWSUITSSerious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe policy notes it is specifically targeting flavored products, which appeal to kids, including fruit and mint flavors sold in cartridges for e-cigarettes, like the popular JUUL pods. Any company that does not cease manufacture, distribution and sale of such products within 30 days faces enforcement action from the FDA.However, the FDA noted that it does not consider the policy a โbanโ on the products, as it is reviewing pre-market applications for potential future flavored products. However, to be approved, such products must meet rigorous criteria that shows how they will not be a danger to children or public health. Some have noted it is unclear whether any flavored e-cigarette product could ever meet that criteria.โThe United States has never seen an epidemic of substance use arise as quickly as our current epidemic of youth use of e-cigarettes,โ Health and Human Services Secretary Alex Azar said in the press release. โBy prioritizing enforcement against the products that are most widely used by children, our action today seeks to strike the right public health balance by maintaining e-cigarettes as a potential off-ramp for adults using combustible tobacco while ensuring these products donโt provide an on-ramp to nicotine addiction for our youth. We will not stand idly by as this crisis among Americaโs youth grows and evolves, and we will continue monitoring the situation and take further actions as necessary.โAccording to a recent study by federal health officials, a quarter of all high school students indicate they have vaped within the last 30 days this year.The new policy takes the form of a final guidance on FDA enforcement policy, since regulations already allow the agency to snatch virtually any vaping product off the market that involves nicotine, since none were ever approved by the agency in the first place. It targets cartridge-based products, but does not affect so-called โtankโ style vaping devices, which use liquid nicotine, and are not as popular among minors, since they tend to be large, obvious, more expensive, and unleash voluminous amounts of visible vapor, making their use hard to hide.In contrast, vape pods like JUUL are tiny, designed to look like USB drives, and emit no visible vapor.JUUL has become the most popular form of e-cigarette since it was introduced in 2015, and the manufacturer has been criticized for following the marketing strategy previously employed by the tobacco industry, targeting younger users to create life-long users of their products. The vape pods are designed in a way that make it even easier for users to inhale large quantities of nicotine without noticing, increasing the addictiveness of JUULing.JUUL removed most of its flavored products from the market last year, even pulling its last holdout and most popular flavor, mint, in November. However, the action will also apply to products like NJOY and other e-cigarettes. Media reports indicate the restriction to cartridge-based products was a compromise between the Trump administration and lobbyists from the vaping industry.Earlier plans reportedly were to announce a actual ban industry wide, and to include menthol.The enforcement action is the second prong in an effort to curb the use of tobacco and nicotine products by minors and comes shortly after a national law raised the age to buy tobacco and e-cigarettes to 21.The FDAโs enforcement priority, however, uses very broad language that could stretch beyond flavored products to almost any electronic nicotine delivery system (ENDS) if it sees them as a problem. According to the press release, enforcement will apply to groups of products that do not have premarket authorization, including:โAny flavored, cartridge-based ENDS products (other than a tobacco- or menthol- flavored ENDS product;All other ENDS products for which the manufacturer has failed to take (or is failing to take) adequate measures to prevent minorsโ access; andAny ENDS product that is targeted to minors or likely to promote use of ENDS by minors.โThe agency defines cartridges as any type of ENDS product using a cartridge or pod with liquid meant to be aerosolized when used. Cartridges are any small, enclosed unit, sealed or unsealed, designed to fit with or operate as part of an ENDS product.JUUL LawsuitsDozens ofย JUULing addiction lawsuitsย and class action lawsuits have been filed against the company in recent months, each raising allegations that the e-cigarette manufacturer marketed their products toward minors and prior non-smokers, while failing to warn that JUUL pods are more potent and addictive than traditional cigarettes.As more parents and young adults step forward toย pursue claims after becomingย addicted to JUUL, it is widely expected that thousands of cases will be presented throughout the federal court system.In October, the U.S. Judicial Panel on Multidistrict Litigation issued an orderย consolidating all JUUL casesย pending throughout the federal court system before Judge William H. Orrick III, in the U.S. District Court for the Northern District of California, which is where JUUL Labs, Inc.โs San Francisco headquarters are located. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Children, E-Cigarettes, Electronic Cigarettes, Juul, Liquid Nicotine, Nicotine, NJOY, VapingMore JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Recalled Omnipod 5 Injuries Skyrocket, Prompting Removal of Insulin Pump Pods (Posted: today)Insulet is removing certain Omnipod 5 insulin pump pods from use following a surge in reports of insulin delivery failures that raise risks of diabetic ketoacidosis and other serious complications.MORE ABOUT: OMNIPOD RECALL LAWSUITInsulet OmniPod 5 Recall Lawsuits May Be Filed Over Problems Resulting in Diabetic Ketoacidosis, Hospitalization and Death (03/24/2026)Omnipod 5 Insulin Pump Recall Follows Reports of Serious Injuries: FDA (03/20/2026) Lawsuit Claims Abbott, Boston Scientific SCS Pre-Market Approval Supplements Caused Permanent Injuries (Posted: yesterday)A Florida womanโs lawsuit alleges that Abbott Laboratories and Boston Scientific altered their SCS device batteries, firmware and stimulation features without adequate safety testing approved by the FDA.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITJPML Sets Hearing Over Spinal Cord Stimulator Lawsuit Consolidation for May 28 (04/24/2026)SCS Injury Lawsuit Alleges Unlicensed Abbott Representatives Modified Device After Implantation (04/20/2026)WaveWriter Alpha Lawsuit Claims Defective Spinal Cord Stimulator Caused Pain and Surgical Removal (04/14/2026) Lawsuit Blames Depo Shot for Brain Tumors, Intense Headaches (Posted: 2 days ago)A Depo-Provera lawsuit filed against Pfizer says the manufacturer knew Depo-Provera could stimulate brain tumor growth before the birth control shots hit the market, yet failed to warn doctors and patients.MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Should Be Added to Birth Control Shot: Lawsuit (04/22/2026)Hearings on Evidence That Depo-Provera Causes Meningioma Brain Tumors Set for Late June 2026 (04/15/2026)High-Risk Brain Tumor From Depo-Provera Requires Frequent Monitoring, Lawsuit Claims (04/06/2026)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Recalled Omnipod 5 Injuries Skyrocket, Prompting Removal of Insulin Pump Pods (Posted: today)Insulet is removing certain Omnipod 5 insulin pump pods from use following a surge in reports of insulin delivery failures that raise risks of diabetic ketoacidosis and other serious complications.MORE ABOUT: OMNIPOD RECALL LAWSUITInsulet OmniPod 5 Recall Lawsuits May Be Filed Over Problems Resulting in Diabetic Ketoacidosis, Hospitalization and Death (03/24/2026)Omnipod 5 Insulin Pump Recall Follows Reports of Serious Injuries: FDA (03/20/2026)
Lawsuit Claims Abbott, Boston Scientific SCS Pre-Market Approval Supplements Caused Permanent Injuries (Posted: yesterday)A Florida womanโs lawsuit alleges that Abbott Laboratories and Boston Scientific altered their SCS device batteries, firmware and stimulation features without adequate safety testing approved by the FDA.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITJPML Sets Hearing Over Spinal Cord Stimulator Lawsuit Consolidation for May 28 (04/24/2026)SCS Injury Lawsuit Alleges Unlicensed Abbott Representatives Modified Device After Implantation (04/20/2026)WaveWriter Alpha Lawsuit Claims Defective Spinal Cord Stimulator Caused Pain and Surgical Removal (04/14/2026)
Lawsuit Blames Depo Shot for Brain Tumors, Intense Headaches (Posted: 2 days ago)A Depo-Provera lawsuit filed against Pfizer says the manufacturer knew Depo-Provera could stimulate brain tumor growth before the birth control shots hit the market, yet failed to warn doctors and patients.MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Should Be Added to Birth Control Shot: Lawsuit (04/22/2026)Hearings on Evidence That Depo-Provera Causes Meningioma Brain Tumors Set for Late June 2026 (04/15/2026)High-Risk Brain Tumor From Depo-Provera Requires Frequent Monitoring, Lawsuit Claims (04/06/2026)